Skip to main content
Livermore
Livermore
ZHEN

BVF Inc

SEC CIK
0001056807
Latest filing
Aug 14, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by BVF Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q2 2026)
16,001,284
Value
$311.5M
% of portfolio
8.0%
Quarters held
17
Since Q2 2022
Holdings of MLTX by BVF Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,001,284$311.5M8.0%00.0%UnchangedHolders
Q1 202616,001,284$298.3M9.5%−3,750,000−19.0%ReducedHolders
Q4 202519,751,284$260.3M8.8%00.0%UnchangedHolders
Q3 202519,751,284$141.6M5.7%00.0%UnchangedHolders
Q2 202519,751,284$932.3M33.3%00.0%UnchangedHolders
Q1 202519,751,284$771.7M31.5%00.0%UnchangedHolders
Q4 202419,751,284$1.07B36.2%−2,000,000−9.2%ReducedHolders
Q3 202421,751,284$1.10B32.1%00.0%UnchangedHolders
Q2 202421,751,284$956.4M26.8%00.0%UnchangedHolders
Q1 202421,751,284$1.09B30.0%00.0%UnchangedHolders
Q4 202321,751,284$1.31B32.9%00.0%UnchangedHolders
Q3 202321,751,284$1.24B33.4%00.0%UnchangedHolders
Q2 202321,751,284$1.11B30.9%00.0%UnchangedHolders
Q1 202321,751,284$465.3M17.0%00.0%UnchangedHolders
Q4 202221,751,284$228.4M9.6%00.0%UnchangedHolders
Q3 202221,751,284$173.1M7.2%00.0%UnchangedHolders
Q2 202221,751,284$114.2M5.5%+21,751,284NewHolders